fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Conjugated estrogens

Form:

2 of 2 products shown

1 general benefit · 1 Limited Use

Premarin · DIN 02414686 · 0.625 mg · extended release tablet

Limited Use, Reason for Use code 398 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 398 required
Write on scriptReason for Use code 398 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 398
Reason for Use code 398 For short-term use in women who are experiencing symptoms of menopause. Note: Recent evidence has demonstrated that use of hormone replacement therapy (HRT) increases the rate of coronary events, breast cancer, dementia, stroke, venous thromboembolism and referrals for abnormal vaginal bleeding. These risks should be discussed with patients and reviewed periodically. Coverage limit: LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Premarin · DIN 02414686 Manufacturer: Pfizer Canada Inc.; listing date 2015-01-28 Health Canada: Marketed since 2014-10-03 · brand PREMARIN · ATC G03CA57 CONJUGATED ESTROGENS · form Tablet (extended-release) · route Oral · ingredients CONJUGATED ESTROGENS 0.625 MG · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Premarin: Formulary list price $0.42 per unit (the source does not state the unit; exact figure $0.4165). What the ministry pays, not the patient.

Ministry pays: $0.4165 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02414686)

Source record
DIN 02414686: Premarin Raw flags: sec12=Y, sec3=Y Item: 681600075; group id 731; item number 1795; lccId 00172; manufacturer id PFI Source form: SR Tab; strength: 0.625mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $0.4165; ministry $0.4165 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02414686 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89931
Shortage status: resolved shortage (ended August 12, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02414686
Shortage record checked October 6, 2026

Premarin Vaginal Cream · DIN 02043440 · 0.625 mg/g · Vag Cr

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
Premarin Vaginal Cream · DIN 02043440 Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01 Health Canada: Marketed since 2012-06-19 · brand PREMARIN VAGINAL CREAM · ATC G03CA57 CONJUGATED ESTROGENS · form Cream · route Vaginal · ingredients CONJUGATED ESTROGENS 0.625 MG/G · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Premarin Vaginal Cream: Formulary list price $0.93 per unit (the source does not state the unit; exact figure $0.9283). What the ministry pays, not the patient.

Ministry pays: $0.9283 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02043440)

Source record
DIN 02043440: Premarin Vaginal Cream Raw flags: sec3=Y Item: 681600007; group id 732; item number 1796; lccId None; manufacturer id PFI Source form: Vag Cr; strength: 0.625mg/g Recorded listing: General benefit Source prices (unrounded): $0.9283; ministry $0.9283 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02043440 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15704
Shortage status: active shortage (reported June 30, 2026, last updated August 18, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02043440
Shortage record checked October 6, 2026

Other products in the same Health Canada class (G03CA): coverage varies; not interchangeable

  • Estradiol (Estrace): general benefit, not a benefit
  • B + estradiol (Vagifem 10): general benefit
  • Estradiol hemihydrate (Imvexxy): general benefit
Other drugs in the same formulary class (68:16 Estrogens) and how they are covered

Matched class: 68:16 Estrogens

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ESTRADIOL 17-B, ESTRADIOL HEMIHYDRATE, ESTRADIOL HEMIHYDRATE & PROGESTERONE Some products covered without a code (check the product listing): ESTRADIOL 68:16 Estrogens

ESTRADIOL

· 7 products · Listed, not a benefit (3), General benefit (4) · strengths: 0.5mg, 1mg, 2mg · Tab, Vag Ring

ESTRADIOL 17-B

· 1 products · General benefit · strengths: 10mcg · Vag Tab with Applicator

ESTRADIOL HEMIHYDRATE

· 2 products · General benefit · strengths: 4mcg, 10mcg · Vag Insert

ESTRADIOL HEMIHYDRATE & PROGESTERONE

· 1 products · General benefit · strengths: 1mg & 100mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 68:16
Full class listing Related classes: 68:04 Corticosteroids, 68:08 Androgens, 68:12 Contraceptives, 68:20 Anti-Diabetic Agents, 68:24 Parathyroid Agents, 68:28 Pituitary Agents, 68:32 Progestogens and Oral Contraceptives, 68:36 Thyroids, 68:38 Anti-Thyroids Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE Premarin® Vaginal Cream is indicated in the treatment of atrophic vaginitis, dyspareunia, and kraurosis vulvae. PREMARIN® VAGINAL CREAM HAS NOT BEEN SHOWN TO BE EFFECTIVE FOR ANY PURPOSE DURING PREGNANCY AND ITS USE MAY CAUSE SEVERE HARM TO THE FETUS. Premarin® Vaginal Cream should be prescribed with an appropriate dose of a progestin for women with intact uteri in order to prevent endometrial hyperplasia/carcinoma Geriatrics (> 65 years of age): See above indications. Pediatrics (< 16 years of age): Premarin® Vaginal Cream is not indicated for use in children. https://pdf.hres.ca/dpd_pm/00081174.PDF PM date: JUN 26, 2025 Source product: PREMARIN VAGINAL CREAM; DIN 02043440; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Premarin Vaginal Cream · DIN 02043440 Shortage status: active shortage (reported 2026-06-30, last updated 2026-08-18); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02043440

Check this DIN again